*By Mike Teich*
Amazon shares jumped nearly 4 percent Friday after the e-commerce juggernaut delivered blockbuster earnings results on Thursday.
The tech giant impressed investors by delivering operating profit of $1.9 billion. Amazon's blockbuster numbers reflected its success in retail sales and growth in its cloud services business, said Michael Pachter, an analyst from Wedbush Securities.
Amazon also announced that it would be raising its Prime membership fee by $20, up to $119 a year. Pachter said the "odds are less than 1 percent that there is a decline in membership" as a result of the price hike.
Pachter compared Amazon Prime's cost to Netflix, noting that Prime was priced below Amazon's video-streaming rival and offers content that is "75 percent as good."
Best Buy lowered its sales outlook for the rest of the year despite a positive quarterly earnings report.
X Corp, formerly known as Twitter, is facing over 2,200 arbitration cases.
Google Flight added a new feature that tracks flight prices.
Businesses posted far fewer open jobs in July and the number of Americans quitting their jobs fell sharply for the second straight month, clear signs that the labor market is cooling in a way that could reduce inflation.
American Airlines said it was fined $4.1 million for keeping passengers on planes during long on-ground delays.
3M said it will pay $6 billion to settle lawsuits claiming that it sold defective earplugs to the U.S. military.
Meta said it disrupted a campaign of disinformation linked to Chinese law enforcement.
Buying your first home can be challenging with rising interest rates and other costs. Cheddar News spoke with Amira Elgoneimy, a premiere agent with Redfin who caters to the New Brunswick, NJ area, and Daryl Fairweather, chief economist with Redfin, about the process involved in purchasing a residence in a competitive market.
Experts from Redfin real estate brokerage explain the challenges buyers are experiencing as they try to buy their first homes.
The Biden administration is targeting the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications for Medicare's first-ever drug price negotiations as it seeks to lower medical costs for Americans.
